Ward Keith Wayne 4
4 · REATA PHARMACEUTICALS INC · Filed Feb 1, 2019
Insider Transaction Report
Form 4
Ward Keith Wayne
See Remarks
Transactions
- Conversion
Class B common stock
2019-01-31−4,150→ 0 total→ Class A common stock (4,150 underlying) - Sale
Class A common stock
2019-01-31$76.97/sh−2,750$211,661→ 8,620 total - Exercise/Conversion
Class B common stock
2019-01-31$11.62/sh+4,150$48,223→ 4,150 total→ Class A common stock (4,150 underlying) - Sale
Class A common stock
2019-01-31$76.17/sh−1,400$106,641→ 11,370 total - Conversion
Class A common stock
2019-01-31+4,150→ 12,770 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-01-31−4,150→ 8,367 totalExercise: $11.62Exp: 2023-06-15→ Class B common stock (4,150 underlying)
Footnotes (5)
- [F1]The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $75.68 to $76.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $76.73 to $77.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013.